Related Experiment Video
Updated: Jun 13, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Antiplatelet agents and risk factors for bleeding postcarotid endarterectomy
David A Payne1, Michael W Twigg, Paul D Hayes
1Department of Cardiovascular Sciences, Leicester Royal Infirmary, Infirmary Square, Leicester, United Kingdom.
Insights
This study found no increased bleeding risk from newer antiplatelet drugs after carotid endarterectomy (CEA). However, controlling hypertension before and after CEA surgery is crucial to prevent complications and reduce hospital stays.
Area of Science:
- Vascular Surgery
- Cardiology
- Anesthesiology
Background:
- Antiplatelet therapy is a potential risk factor for wound hematoma after carotid endarterectomy (CEA).
- The study addresses the increasing use of diverse antiplatelet drugs and their impact on post-CEA bleeding.
Purpose of the Study:
- To audit the incidence of re-operation for bleeding following carotid endarterectomy (CEA).
- To investigate the association between antiplatelet drug use and postoperative bleeding complications.
Main Methods:
- Prospective data collection from 448 patients undergoing CEA between 1997 and 2001.
- Case-controlled analysis comparing patients with postoperative bleeding requiring exploration to matched controls.
- Assessment of demographics, drug history, and perioperative care.
Main Results:
- 6.03% of patients (27/448) required re-exploration for bleeding.
- No increased bleeding risk was associated with antiplatelet drug use on univariate analysis.
- Post-CEA hypertension was significantly more prevalent in patients requiring re-exploration (p = 0.014).
- Re-exploration correlated with higher transfusion needs (p ≤ 0.0001) and longer hospital stays (p = 0.001) without increased morbidity or mortality.
Conclusions:
- Newer antiplatelet agents do not appear to increase bleeding risk after CEA.
- Effective blood pressure management, both pre- and post-surgery, is critical for reducing bleeding complications.
- A protocol for managing hypertension post-CEA is recommended.
Background:
Antiplatelet therapy has been implicated as a risk factor for wound hematoma formation after carotid endarterectomy (CEA). Given the increasing use of alternative antiplatelet drugs acting through differing inhibitory pathways, we audited the incidence of re-operation for bleeding post-CEA.
Methods:
Data were prospectively recorded on all patients undergoing CEA in Leicester, United Kingdom between November 1997 and October 2001. The data from those requiring exploration for bleeding were studied on a case-controlled basis using paired age and sex-matched controls from within the overall database. Assessment of the patients' demographics, drug history, and intraoperative and postoperative care was made.
Results:
A total of 448 patients were reviewed and 27 (6.03%) cases of postoperative bleeding were identified which required exploration. Despite the prevalent use of antiplatelet drugs before surgery, there was no increased risk of bleeding associated with their use identified on univariate analysis. Patients who underwent re-exploration for bleeding had a significantly greater prevalence of post-CEA hypertension (21/27 cases vs. 25/54 controls, respectively; p = 0.014). Patients who underwent surgical re-exploration for bleeding also had a greater transfusion requirement (1.33 ± 1.3 vs. 0.02 ± 0.1 units; p ≤ 0.0001) and a longer hospital stay (4.9 ± 2.2 days vs. 2.9 ± 2.3 days; p = 0.001) although there was no increase in morbidity or mortality.
Conclusion:
The use of newer antiplatelet drugs before surgery was not associated with an increased risk of bleeding after CEA in this study. Tight control of blood pressure, both pre- and postsurgery, appears to be important, and a protocol for the management of this condition is recommended.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:22Aneurysm IV: Nursing Management
01:27Peripheral Artery Disease III: Interprofessional Care
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:23Peripheral Artery Disease V: Postoperative Nursing Management
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...